Important drug-micronutrient interactions: A selection for clinical practice

被引:24
|
作者
Groeber, Uwe [1 ]
Schmidt, Joachim [1 ]
Kisters, Klaus [1 ,2 ]
机构
[1] Acad Micronutrient Med, Essen, Germany
[2] St Anna Hosp, Med Klin 1, Herne, Germany
关键词
Micronutrient; drug; interactions; proton pump inhibitors; vitamin B12; magnesium; Metformin; thiazide diuretics; statins; selenium; vitamin D; coenzyme Q10; PROTON-PUMP INHIBITOR; IRON-DEFICIENCY ANEMIA; STATIN-ASSOCIATED MYOPATHY; SERUM METHYLMALONIC ACID; RECEPTOR ANTAGONIST USE; VITAMIN-D DEFICIENCY; LONG-TERM TREATMENT; MUSCLE SYMPTOMS; COBALAMIN DEFICIENCY; HELICOBACTER-PYLORI;
D O I
10.1080/10408398.2018.1522613
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Interactions between drugs and micronutrients have received only little or no attention in the medical and pharmaceutical world in the past. Since more and more pharmaceutics are used for the treatment of patients, this topic is increasingly relevant. As such interactions-depending on the duration of treatment and the status of micronutrients-impact the health of the patient and the action of the drugs, physicians and pharmacists should pay more attention to such interactions in the future. This review aims to sensitize physicians and pharmacists on drug micronutrient interactions with selected examples of widely pescribed drugs that can precipitate micronutrient deficiencies. In this context, the pharmacist, as a drug expert, assumes a particular role. Like no other professional in the health care sector, he is particularly predestined and called up to respond to this task. The following article intends to point out the relevance of mutual interactions between micronutrients and various examples of widely used drugs, without claiming to be exhaustive.
引用
收藏
页码:257 / 275
页数:19
相关论文
共 50 条
  • [21] CLINICALLY IMPORTANT DRUG INTERACTIONS
    PRESCOTT, LF
    DRUGS, 1973, 5 (03) : 161 - 186
  • [22] Important Drug Interactions in Dermatology
    Thomas Christian Roos
    Hans Friedrich Merk
    Drugs, 2000, 59 : 181 - 192
  • [23] Drug-drug interactions in HCV therapy: Still relevant for clinical practice?
    Schulte, Benjamin
    Wubbolding, Maximilian
    Port, Kerstin
    Manns, Michael P.
    Back, David
    Marra, Fiona
    Cornberg, Markus
    Maasoumy, Benjamin
    zu Siederdissen, Christoph Hoener
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E240 - E240
  • [24] Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Corsini, Alberto
    Ferri, Nicola
    Proietti, Marco
    Boriani, Giuseppe
    DRUGS, 2020, 80 (11) : 1065 - 1083
  • [25] Drug-Drug Interactions Involving Dexamethasone in Clinical Practice: Myth or Reality?
    Bourdin, Venceslas
    Bigot, William
    Vanjak, Anthony
    Burlacu, Ruxandra
    Lopes, Amanda
    Champion, Karine
    Depond, Audrey
    Amador-Borrero, Blanca
    Sene, Damien
    Comarmond, Chloe
    Mouly, Stephane
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [26] Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice
    Alberto Corsini
    Nicola Ferri
    Marco Proietti
    Giuseppe Boriani
    Drugs, 2020, 80 : 1065 - 1083
  • [27] BENZODIAZEPINE DRUG-DRUG INTERACTIONS COMMONLY OCCURRING IN CLINICAL-PRACTICE
    ABERNETHY, DR
    GREENBLATT, DJ
    OCHS, HR
    SHADER, RI
    CURRENT MEDICAL RESEARCH AND OPINION, 1984, 8 : 80 - 93
  • [28] Important Drug-Drug Interactions in the Elderly
    Ruth M. Seymour
    Philip A. Routledge
    Drugs & Aging, 1998, 12 : 485 - 494
  • [29] Important drug-drug interactions in the elderly
    Seymour, RM
    Routledge, PA
    DRUGS & AGING, 1998, 12 (06) : 485 - 494
  • [30] Important drug-drug interactions of antipsychotics
    Bobes Garcia, J.
    EUROPEAN PSYCHIATRY, 2019, 56 : S658 - S658